Aqr Capital Management LLC Kala Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$6.24 - $9.58 $127,433 - $195,642
-20,422 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$6.28 - $8.79 $83,806 - $117,302
-13,345 Reduced 39.52%
20,422 $138,000
Q3 2020

Nov 16, 2020
BUY
$7.5 - $11.11 $97,162 - $143,930
12,955 Added 62.25%
33,767 $253,000
Q2 2020

Aug 17, 2020
BUY
$8.33 - $13.79 $173,363 - $286,997
20,812 New
20,812 $219,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.08M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email